Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 8.23% is 18% above its 5-year average of 6.99%, near the high end of its 5-year range (2.94%–8.80%).
As of the fiscal period ended Wednesday, December 31, 2025. 2.14% below its 12-month average of 8.41%.
Annual fiscal-year return on invested capital; no daily interpolation.
RETURN ON INVESTED CAPITAL (ROIC)
8.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
8.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
8.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
6.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
6.48%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
10.22%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-2.14%
CURRENT VS 3Y AVG
0.00%
CURRENT VS 5Y AVG
+17.68%
CURRENT VS 10Y AVG
+27.08%
CURRENT VS 15Y AVG
-19.44%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.53%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-3.52%
vs the sector median at left
IQVIA Holdings Inc.
Market Cap
$38.68B
Return on Invested Capital (ROIC)
8.23%
TTM Avg
8.41%
3Y Avg
8.23%
5Y Avg
6.99%
Market Cap
$39.08B
Return on Invested Capital (ROIC)
12.57%
TTM Avg
12.57%
3Y Avg
13.57%
5Y Avg
12.73%
Market Cap
$43.67B
Return on Invested Capital (ROIC)
3.12%
TTM Avg
3.25%
3Y Avg
5.37%
5Y Avg
7.01%
Market Cap
$44.10B
Return on Invested Capital (ROIC)
40.27%
TTM Avg
37.07%
3Y Avg
34.89%
5Y Avg
35.94%
Market Cap
$33.22B
Return on Invested Capital (ROIC)
5.69%
TTM Avg
6.03%
3Y Avg
3.95%
5Y Avg
3.95%
Market Cap
$32.40B
Return on Invested Capital (ROIC)
21.54%
TTM Avg
21.87%
3Y Avg
20.30%
5Y Avg
19.27%
Market Cap
$31.49B
Return on Invested Capital (ROIC)
16.61%
TTM Avg
13.40%
3Y Avg
11.07%
5Y Avg
9.62%
Market Cap
$30.74B
Return on Invested Capital (ROIC)
-13.41%
TTM Avg
-4.17%
3Y Avg
-0.53%
5Y Avg
0.76%
Market Cap
$30.72B
Return on Invested Capital (ROIC)
8.84%
TTM Avg
8.56%
3Y Avg
8.37%
5Y Avg
9.38%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IQVIA Holdings Inc. (IQV) | $38.68B | 8.23% | 8.41% | 8.23% | 6.99% |
| Agilent Technologies, Inc. (A)vs › | $39.08B | 12.57% | 12.57% | 13.57% | 12.73% |
| Humana Inc. (HUM)vs › | $43.67B | 3.12% | 3.25% | 5.37% | 7.01% |
| IDEXX Laboratories, Inc. (IDXX)vs › | $44.10B | 40.27% | 37.07% | 34.89% | 35.94% |
| Medline Inc. (MDLN)vs › | $33.22B | 5.69% | 6.03% | 3.95% | 3.95% |
| Zoetis Inc. (ZTS)vs › | $32.40B | 21.54% | 21.87% | 20.30% | 19.27% |
| DexCom, Inc. (DXCM)vs › | $31.49B | 16.61% | 13.40% | 11.07% | 9.62% |
| Centene Corp. (CNC)vs › | $30.74B | -13.41% | -4.17% | -0.53% | 0.76% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $30.72B | 8.84% | 8.56% | 8.37% | 9.38% |
| ResMed Inc. (RMD)vs › | $30.60B | 19.56% | 18.66% | 17.73% | 16.77% |
ROIC
8.2%
ROE
22.3%
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 8.23% |
| 2024-12-31 | 8.59% |
| 2023-12-31 | 8.80% |
| 2022-12-31 | 7.30% |
| 2021-12-31 | 6.10% |
| 2020-12-31 | 2.94% |
| 2019-12-31 | 2.65% |
| 2018-12-31 | 3.21% |
| 2017-12-31 | 3.59% |
| 2016-12-31 | 0.56% |
| 2015-12-31 | 19.27% |
| 2014-12-31 | 22.64% |
| 2013-12-31 | 20.38% |
| 2012-12-31 | 20.97% |
| 2011-12-31 | 28.22% |
| 2010-12-31 | 0.00% |
